New treatment options for obesity and lipoprotein disorders reported in recent patents April 24, 2008
Recent GSK and Peakdale patents describe new treatment options for endocrine-related disorders April 23, 2008
Sirtris reports results from phase Ib clinical trial of resveratrol for type 2 diabetes April 23, 2008
CSL Behring submits NDS to Health Canada for approval of C1-esterase inhibitor for HAE April 22, 2008
Insmed receives U.K. approval to initiate phase I study of follow-on biologic of Neupogen April 21, 2008